Advanced Life Sciences acquires new Woodridge
headquarters
41,000 sq. ft. laboratory/office facility will further
expansion of the Argonne Biotech Corridor
Woodridge, Ill, April 22, 2003 - Advanced Life Sciences, Inc.
(ALS) has completed a deal to purchase a 41,000 sq. ft. building
in Woodridge that will house the company's corporate headquarters
and R&D laboratory facilities, announced Michael T. Flavin,
Ph.D., ALS's chief executive officer.
The new facility, to be called the ALS Product Development Center
& Headquarters, will be located at 1440 Davey Rd., nearby
the company's existing offices. The first phase of build out will
include corporate offices and the expansion of laboratory operations.
This expansion to include laboratory operations will give Advanced
Life Sciences more control over critical issues and decisions
encountered in the early stages of drug discovery and development.
In addition, the added laboratory capabilities enhance ALS' position
as an attractive collaborative partner to other pharmaceutical
and biotechnology companies.
"We believe that the location of our new facility, as well
as our expansion of operations, will have a direct and positive
impact on the further realization of the Argonne Biotechnology
Corridor, a fast growing biotechnology area, anchored by Argonne
National Laboratory," Dr. Flavin said. "The Chicago
Technology Park anchors a strong city-based arm of biotechnology.
A third arm has developed from the Northwestern Research Park
and continues up the North Shore to the headquarters of Abbott
and Baxter. The Argonne Corridor, the Tech Park and the North
Shore Corridor are all centers of excellence in discovery and
development that are helping to establish Chicago's position as
a world-class biotechnology hub."
Dr. Flavin noted that he expects the new headquarters to be completed
in time for October occupancy. At full capacity the facility will
house up to 50 scientists and business professionals.
"We are delighted to welcome Advanced Life Science's new
corporate headquarters and product development center to Woodridge,"
said William Murphy, Woodridge mayor. "We were extremely
pleased that they selected Woodridge a third time for their continuing
expansion. Their decision is evidence that Woodridge's easy access
and proximity to Argonne National Laboratories offers an ideal
location for biotechnology facilities. We have enjoyed having
Advanced Life Sciences as a part of our business community and
look forward to their continued success in Woodridge."
Advanced Life Sciences is a privately held biopharmaceutical
company engaged in the discovery, development and commercialization
of novel drugs in the therapeutic areas of infection, cancer and
inflammation using its platform in natural products and chemical
proteomics coupled with expertise in drug development. (www.advancedlifesciences.com)
###